Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)

被引：50

作者：

Porat, Yaara ^{[1
]}

Giladi, Moshe ^{[1
]}

Schneiderman, Rosa S. ^{[1
]}

Blat, Roni ^{[1
]}

Shteingauz, Anna ^{[1
]}

Zeevi, Einav ^{[1
]}

Munster, Mijal ^{[1
]}

Voloshin, Tali ^{[1
]}

Kaynan, Noa ^{[1
]}

Tal, Orna ^{[1
]}

Kirson, Eilon D. ^{[2
]}

Weinberg, Uri ^{[3
]}

Palti, Yoram ^{[2
]}

机构：

[1] Novocure Ltd, Preclin Res Dept, Haifa, Israel

[2] Novocure Ltd, Haifa, Israel

[3] Novocure GmbH, Luzern, Switzerland

来源：

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2017年 / 123期

关键词：

Cancer Research; Issue; 123; Tumor Treating Fields; TTFields; inovitro; glioma; ovarian cancer; frequency scan; ALTERNATING ELECTRIC-FIELDS; PHYSICIANS CHOICE CHEMOTHERAPY; IN-VITRO; LUNG-CANCER; COMBINATION; DISRUPTION; VIVO; GLIOBLASTOMA; THERAPY; SYSTEM;

D O I：

10.3791/55820

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Tumor Treating Fields (TTFields) are an effective treatment modality delivered via the continuous, noninvasive application of low-intensity (1-3 V/cm), alternating electric fields in the frequency range of several hundred kHz. The study of TTFields in tissue culture is carried out using the TTFields in vitro application system, which allows for the application of electric fields of varying frequencies and intensities to ceramic Petri dishes with a high dielectric constant (epsilon > 5,000). Cancerous cell lines plated on coverslips at the bottom of the ceramic Petri dishes are subjected to TTFields delivered in two orthogonal directions at various frequencies to facilitate treatment outcome tests, such as cell counts and clonogenic assays. The results presented in this report demonstrate that the optimal frequency of the TTFields with respect to both cell counts and clonogenic assays is 200 kHz for both ovarian and glioma cells.

引用

页数：8

共 50 条

[21] A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights [J].

Li, Xing ;

Liu, Kaida ;

Xing, Lidong ;

Rubinsky, Boris .

RADIOLOGY AND ONCOLOGY, 2023, 57 (03) :279-291

[22] AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields) [J].

Shteingauz, Anna ;

Porat, Yaara ;

Voloshin, Tali ;

Schneiderman, Rosa S. ;

Munster, Mijal ;

Zeevi, Einav ;

Kaynan, Noa ;

Gotlib, Karnit ;

Giladi, Moshe ;

Kirson, Eilon D. ;

Weinberg, Uri ;

Kinzel, Adrian ;

Palti, Yoram .

CELL DEATH & DISEASE, 2018, 9

[23] Anti-cancer mechanisms of action of therapeutic alternating electric fields (tumor treating fields [TTFields]) [J].

Shams, Shadi ;

Patel, Chirag B. .

JOURNAL OF MOLECULAR CELL BIOLOGY, 2022, 14 (08)

[24] Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo [J].

Davidi, Shiri ;

Jacobovitch, Sara ;

Shteingauz, Anna ;

Martinez-Conde, Antonia ;

Braten, Ori ;

Tempel-Brami, Catherine ;

Zeevi, Einav ;

Frechtel-Gerzi, Roni ;

Ene, Hila ;

Dor-On, Eyal ;

Voloshin, Tali ;

Tzchori, Itai ;

Haber, Adi ;

Giladi, Moshe ;

Kinzel, Adrian ;

Weinberg, Uri ;

Palti, Yoram .

CANCERS, 2022, 14 (12)

[25] Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines [J].

Fishman, Hila ;

Monin, Roni ;

Dor-On, Eyal ;

Kinzel, Adrian ;

Haber, Adi ;

Giladi, Moshe ;

Weinberg, Uri ;

Palti, Yoram .

JOURNAL OF NEURO-ONCOLOGY, 2023, 163 (01) :83-94

[26] The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts [J].

Nancy Ann Oberheim-Bush ;

Wenyin Shi ;

Michael W. McDermott ;

Alexander Grote ;

Julia Stindl ;

Leonardo Lustgarten .

Journal of Neuro-Oncology, 2022, 158 :453-461

[27] Association of tumor treating fields (TTFields) therapy with overall survival in newly diagnosed glioblastoma [J].

Shah, Siddharth ;

Nag, Aiswarya ;

Lucke-Wold, Brandon .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (07) :2904-2912

[28] Case report: durable response of gliomatosis cerebri with concurrent tumor-treating fields (TTFields) and chemoradiotherapy treatment [J].

Desjarlais, Alex M. ;

Miller, Ryan ;

Ali, Ayesha S. ;

Niazi, Muneeb Z. ;

Cappelli, Louis ;

Glass, Jon ;

Farrell, Christopher J. ;

Shi, Wenyin .

CHINESE CLINICAL ONCOLOGY, 2023, 12 (06)

[29] Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance [J].

Berckmans, Yani ;

Ene, Hila M. ;

Ben-Meir, Kerem ;

Martinez-Conde, Antonia ;

Wouters, Roxanne ;

van den Ende, Bieke ;

Van Mechelen, Sara ;

Monin, Roni ;

Frechtel-Gerzi, Roni ;

Gabay, Hila ;

Dor-On, Eyal ;

Haber, Adi ;

Weinberg, Uri ;

Vergote, Ignace ;

Giladi, Moshe ;

Coosemans, An ;

Palti, Yoram .

FRONTIERS IN ONCOLOGY, 2024, 14

[30] Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region [J].

Anadkat, Milan J. ;

Lacouture, Mario ;

Friedman, Adam ;

Horne, Zachary D. ;

Jung, Jae ;

Kaffenberger, Benjamin ;

Kalmadi, Sujith ;

Ovington, Liza ;

Kotecha, Rupesh ;

Abdullah, Huda Ismail ;

Grosso, Federica .

FRONTIERS IN ONCOLOGY, 2023, 12

← 1 2 3 4 5 →